Nextgen Biomed Ltd
Symbol: NXGN.TA
TLV
101.8
ILAMarktpreis heute
-106.3909
P/E-Verhältnis
0.0000
PEG-Verhältnis
7.56M
MRK Kapital
- 0.00%
DIV Rendite
Nextgen Biomed Ltd (NXGN-TA) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 5.2 | 12 | 5.7 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 0 | 5.3 | 12.3 | 5.9 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1.6 | 7.3 | 0 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 8.1 | 4.1 | 2.4 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 9.6 | 11.4 | 2.4 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 14.9 | 23.6 | 8.3 | |||||||||
balance-sheet.row.account-payables | 0 | 0.2 | 0.1 | 0.1 | |||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 1.1 | 0.6 | 1.4 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 1.4 | 2.1 | 0 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 0 | 2.6 | 2.9 | 1.5 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.retained-earnings | 0 | -51.9 | -43.3 | -40.7 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 64.2 | 64.1 | 47.7 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 12.4 | 20.8 | 7 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 14.9 | 23.6 | 8.3 | |||||||||
balance-sheet.row.minority-interest | 0 | -0.1 | -0.1 | -0.1 | |||||||||
balance-sheet.row.total-equity | 0 | 12.3 | 20.7 | 6.9 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-debt | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.net-debt | 0 | -5.2 | -12 | -5.7 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -8.6 | -2.5 | -1.3 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 5 | -0.1 | 0 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0.2 | 0.2 | 0 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 0.7 | 0 | -0.2 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | 0 | -0.1 | 0 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.5 | 0 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | -0.5 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -2 | -1.9 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4 | -2.5 | -2.4 | ||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 11.4 | 7 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 0 | 0.7 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 11.4 | 7.7 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | -6.7 | 6.3 | 3.8 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 5.2 | 11.9 | 5.7 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 12 | 5.7 | 1.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | -2.8 | -2.7 | -1.5 | ||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -0.5 | 0 | ||||||||||
cash-flows.row.free-cash-flow | 0 | -2.8 | -3.2 | -1.5 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | -5 | 0 | 0 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 3.6 | 2.8 | 1.3 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3.6 | 2.8 | 1.3 | ||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.3 | 0 | ||||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0 | 0 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0.7 | 0.3 | 0 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | -5 | 0 | 0 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0.7 | 0.3 | 0 | ||||||||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0 | 0 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | -9.3 | -2.8 | -1.3 | ||||||||||
income-statement-row.row.income-before-tax | 0 | -8.6 | -2.6 | -1.3 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 0.8 | 0.3 | 0 | ||||||||||
income-statement-row.row.net-income | 0 | -8.6 | -2.5 | -1.3 |
Häufig gestellte Frage
Wie hoch ist die Nextgen Biomed Ltd (NXGN.TA) Gesamtvermögen?
Nextgen Biomed Ltd (NXGN.TA) Gesamtvermögen ist 14888000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.000.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.200.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.000.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.000.
Was ist der Nextgen Biomed Ltd (NXGN.TA) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -8572000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 0.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 3581000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.